By Amy Rothman Schonfeld This spring will mark the inaugural biennial conference of the newly formed American Society of Health Economists (ASHE). The conference, titled Economics of Population Health, is…
DetailsBy Robert Hand In the United States, there has been growing acceptance of the Academy of Managed Care Pharmacy (AMCP) Drug Dossier format for submitting consistent, evidence-based information about drugs.…
DetailsBy Ruth Whittington Remember last month’s exhortation to break the firewalls between health economics and sales and marketing? Here is an opposing view from a prominent member of the industry,…
DetailsBy David Woods Nothing is calculated to agitate health economists more than the perception that what you do is somehow inexact, or “soft”. Yet no matter how precise and rigorous…
DetailsBy David Woods, former editor At a recent meeting on healthcare communications, one speaker referred to what he called new innovations. Perhaps his enthusiasm made up for a lack of…
DetailsBy Ruth Whittington (ruth.whittington@rxcomms.com) One of the issues most frequently mentioned when we surveyed you was the seemingly unbridgeable gap between how health economists think, and how marketing and sales…
DetailsGeorge Orwell, whose prose was spare and pure, offered six rules for effective writing: * Never use a metaphor, simile, or other figure of speech which you are used to…
DetailsBy David Woods, editor Before embarking upon this project we wanted to get a solid grip on the issues that keep you awake at night … and how we can…
DetailsIn the current pharmaceutical environment your work is of paramount importance. However, if it’s communicated poorly, and those who need it can’t use it, what value does it really have?…
Details
